400 related articles for article (PubMed ID: 15870145)
41. Febuxostat compared with allopurinol in patients with hyperuricemia and gout.
Becker MA; Schumacher HR; Wortmann RL; MacDonald PA; Eustace D; Palo WA; Streit J; Joseph-Ridge N
N Engl J Med; 2005 Dec; 353(23):2450-61. PubMed ID: 16339094
[TBL] [Abstract][Full Text] [Related]
42. Variation in gout care in Aotearoa New Zealand: a national analysis of quality markers.
Jackson G; Dalbeth N; Te Karu L; Winnard D; Gow P; Gerard C; Minko N
N Z Med J; 2014 Oct; 127(1404):37-47. PubMed ID: 25331310
[TBL] [Abstract][Full Text] [Related]
43. Case 9: initiation of urate-lowering therapy for advanced gout complicated by chronic renal insufficiency.
Edwards NL
Am J Med; 2006 Nov; 119(11 Suppl 1):S29-31. PubMed ID: 17059911
[No Abstract] [Full Text] [Related]
44. Relationship between physician specialty and allopurinol prescribing patterns: a study of patients with gout in managed care settings.
Pandya BJ; Riedel AA; Swindle JP; Becker LK; Hariri A; Dabbous O; Krishnan E
Curr Med Res Opin; 2011 Apr; 27(4):737-44. PubMed ID: 21271794
[TBL] [Abstract][Full Text] [Related]
45. Physician adherence to ACR gout treatment guidelines: perception versus practice.
Oderda GM; Shiozawa A; Walsh M; Hess K; Brixner DI; Feehan M; Akhras K
Postgrad Med; 2014 May; 126(3):257-67. PubMed ID: 24918810
[TBL] [Abstract][Full Text] [Related]
46. Febuxostat: a selective xanthine-oxidase/xanthine-dehydrogenase inhibitor for the management of hyperuricemia in adults with gout.
Ernst ME; Fravel MA
Clin Ther; 2009 Nov; 31(11):2503-18. PubMed ID: 20109996
[TBL] [Abstract][Full Text] [Related]
47. [Establishment of therapeutic goal and plan of gout and asymptomatic hyperuricemia].
Fujimori S
Nihon Rinsho; 2008 Apr; 66(4):729-35. PubMed ID: 18409523
[TBL] [Abstract][Full Text] [Related]
48. Achieving serum urate goal: a comparative effectiveness study between allopurinol and febuxostat.
Hatoum H; Khanna D; Lin SJ; Akhras KS; Shiozawa A; Khanna P
Postgrad Med; 2014 Mar; 126(2):65-75. PubMed ID: 24685969
[TBL] [Abstract][Full Text] [Related]
49. Hyperuricaemia, gout and allopurinol in the CKD Queensland registry.
Jeyaruban A; Hoy W; Cameron A; Healy H; Wang Z; Zhang J; Mallett A
J Nephrol; 2021 Jun; 34(3):753-762. PubMed ID: 33439469
[TBL] [Abstract][Full Text] [Related]
50. A survey of current prescribing practices of antiinflammatory and urate-lowering drugs in gouty arthritis.
Stuart RA; Gow PJ; Bellamy N; Campbell J; Grigor R
N Z Med J; 1991 Mar; 104(908):115-7. PubMed ID: 2011292
[TBL] [Abstract][Full Text] [Related]
51. Improved management of acute gout during hospitalization following introduction of a protocol.
Kamalaraj N; Gnanenthiran SR; Kathirgamanathan T; Hassett GM; Gibson KA; McNeil HP
Int J Rheum Dis; 2012 Dec; 15(6):512-20. PubMed ID: 23253233
[TBL] [Abstract][Full Text] [Related]
52. General practitioners' perspectives on the management of gout: a qualitative study.
Jeyaruban A; Soden M; Larkins S
Postgrad Med J; 2016 Oct; 92(1092):603-7. PubMed ID: 27033862
[TBL] [Abstract][Full Text] [Related]
53. Factors associated with recurrent hospital admissions for gout: a case-control study.
Hutton I; Gamble G; Gow P; Dalbeth N
J Clin Rheumatol; 2009 Sep; 15(6):271-4. PubMed ID: 19734730
[TBL] [Abstract][Full Text] [Related]
54. Gout treatment and comorbidities: a retrospective cohort study in a large US managed care population.
Primatesta P; Plana E; Rothenbacher D
BMC Musculoskelet Disord; 2011 May; 12():103. PubMed ID: 21599917
[TBL] [Abstract][Full Text] [Related]
55. The genetics of gout: towards personalised medicine?
Dalbeth N; Stamp LK; Merriman TR
BMC Med; 2017 May; 15(1):108. PubMed ID: 28566086
[TBL] [Abstract][Full Text] [Related]
56. Patient and clinical characteristics associated with gout flares in an integrated healthcare system.
Rashid N; Levy GD; Wu YL; Zheng C; Koblick R; Cheetham TC
Rheumatol Int; 2015 Nov; 35(11):1799-807. PubMed ID: 25991397
[TBL] [Abstract][Full Text] [Related]
57. Preservation of renal function during gout treatment with febuxostat: a quantitative study.
Whelton A; MacDonald PA; Chefo S; Gunawardhana L
Postgrad Med; 2013 Jan; 125(1):106-14. PubMed ID: 23391676
[TBL] [Abstract][Full Text] [Related]
58. A national survey of Veterans Affairs rheumatologists for relevance of quality of care indicators for gout management.
Singh JA; Alpert MD; Kerr G
Arthritis Care Res (Hoboken); 2010 Sep; 62(9):1306-11. PubMed ID: 20235197
[TBL] [Abstract][Full Text] [Related]
59. Hyperuricaemia and gout.
Shipley M
J R Coll Physicians Edinb; 2011 Sep; 41(3):229-33. PubMed ID: 21949921
[TBL] [Abstract][Full Text] [Related]
60. [Treatment of hyperuricemia and gout].
Gröbner W; Walter-Sack I
Med Monatsschr Pharm; 2005 May; 28(5):159-64; quiz 165-6. PubMed ID: 15912988
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
